MetLife (MET) to Release Earnings on Wednesday

Key Points

• MetLife is set to release its Q2 2025 earnings on August 6th, with analysts predicting earnings of $2.32 per share and revenue of $18.58 billion.
• The company recently announced a $3.00 billion stock buyback plan, indicating confidence from the board in the stock's value.
• In addition, MetLife declared a quarterly dividend of $0.5675 per share, reflecting a dividend yield of 2.92%.

MetLife (NYSE:MET - Get Free Report) is expected to post its Q2 2025 quarterly earnings results after the market closes on Wednesday, August 6th. Analysts expect MetLife to post earnings of $2.32 per share and revenue of $18.58 billion for the quarter.

MetLife (NYSE:MET - Get Free Report) last announced its quarterly earnings results on Wednesday, April 30th. The financial services provider reported $1.96 EPS for the quarter, missing the consensus estimate of $2.00 by ($0.04). MetLife had a net margin of 6.08% and a return on equity of 20.89%. The firm had revenue of $18.57 billion during the quarter, compared to the consensus estimate of $18.06 billion. During the same period in the previous year, the business earned $1.83 earnings per share. The firm's revenue for the quarter was up 15.6% on a year-over-year basis. On average, analysts expect MetLife to post $10 EPS for the current fiscal year and $11 EPS for the next fiscal year.

MetLife Stock Up 0.1%

Shares of NYSE:MET opened at $77.72 on Wednesday. The firm has a fifty day moving average price of $78.56 and a two-hundred day moving average price of $79.62. The company has a debt-to-equity ratio of 0.55, a current ratio of 0.16 and a quick ratio of 0.16. MetLife has a one year low of $65.21 and a one year high of $89.05. The company has a market cap of $52.17 billion, a price-to-earnings ratio of 12.64, a PEG ratio of 0.63 and a beta of 0.85.

MetLife declared that its Board of Directors has approved a stock buyback plan on Wednesday, April 30th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to repurchase up to 5.9% of its shares through open market purchases. Shares repurchase plans are often an indication that the company's board of directors believes its shares are undervalued.

MetLife Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 9th. Shareholders of record on Tuesday, August 5th will be issued a $0.5675 dividend. This represents a $2.27 annualized dividend and a yield of 2.92%. The ex-dividend date of this dividend is Tuesday, August 5th. MetLife's payout ratio is 36.91%.

Institutional Trading of MetLife

Several hedge funds have recently added to or reduced their stakes in the business. Empowered Funds LLC lifted its stake in MetLife by 187.6% in the first quarter. Empowered Funds LLC now owns 33,378 shares of the financial services provider's stock worth $2,680,000 after purchasing an additional 21,771 shares during the last quarter. Brighton Jones LLC increased its position in shares of MetLife by 9.0% in the fourth quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider's stock valued at $347,000 after acquiring an additional 351 shares during the period. Finally, Caxton Associates LLP purchased a new position in shares of MetLife in the first quarter valued at about $307,000. 94.99% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

MET has been the subject of a number of research analyst reports. JPMorgan Chase & Co. lifted their price objective on shares of MetLife from $86.00 to $95.00 and gave the stock an "overweight" rating in a report on Tuesday, July 8th. Piper Sandler lifted their price objective on shares of MetLife from $92.00 to $94.00 and gave the stock an "overweight" rating in a report on Wednesday, April 2nd. Wells Fargo & Company reaffirmed an "overweight" rating and set a $97.00 price objective (up from $94.00) on shares of MetLife in a report on Thursday, July 10th. Keefe, Bruyette & Woods dropped their price objective on shares of MetLife from $95.00 to $94.00 and set an "outperform" rating for the company in a report on Wednesday, July 9th. Finally, Barclays lifted their price objective on shares of MetLife from $88.00 to $94.00 and gave the stock an "overweight" rating in a report on Monday, July 7th. Two investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat, MetLife presently has an average rating of "Moderate Buy" and an average target price of $96.09.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.